This HTML5 document contains 58 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q57767905
rdf:type
wikibase:Item
schema:description
article by Ursula Schmidt-Erfurth et al published May 2014 in Ophthalmology wetenschappelijk artikel im Mai 2014 veröffentlichter wissenschaftlicher Artikel article scientifique publié en 2014 наукова стаття, опублікована в травні 2014
p:P577
wds:Q57767905-AF4AD2B3-E4CD-4922-8AB9-371152ACCBB2
wdt:P577
2014-05-01T00:00:00Z
p:P2093
wds:Q57767905-7392E4FA-7791-448A-9DCD-7D483CA790A4 wds:Q57767905-544454E3-1F8A-443D-B808-9F6133E9F72D wds:Q57767905-339EDA40-36DD-4DEA-8701-49EE12E58461 wds:Q57767905-B73D83E7-2B80-40DB-AB35-BD3793876AC5 wds:Q57767905-B456F926-EB4D-4B77-90C5-F214DB0418CE wds:Q57767905-A37990E3-441B-477E-8FC2-27B4AB85EBE9 wds:Q57767905-7B9910E0-07E9-454F-B5DA-63977310EF0C wds:Q57767905-2BFAB275-D4D9-49D7-AC78-81E29156A150 wds:Q57767905-09DE5E1F-633C-4C2A-9E9B-F5B318DA9B13
wdt:P2093
Haige Shen Ortrud Gerstner Paul Mitchell Gabriele E. Lang Pascale Massin Abdelkader Si Bouazza Aaron Osborne Reinier O. Schlingemann Paolo Lanzetta
rdfs:label
Three-Year Outcomes of Individualized Ranibizumab Treatment in Patients with Diabetic Macular Edema Three-Year Outcomes of Individualized Ranibizumab Treatment in Patients with Diabetic Macular Edema
skos:prefLabel
Three-Year Outcomes of Individualized Ranibizumab Treatment in Patients with Diabetic Macular Edema Three-Year Outcomes of Individualized Ranibizumab Treatment in Patients with Diabetic Macular Edema
schema:name
Three-Year Outcomes of Individualized Ranibizumab Treatment in Patients with Diabetic Macular Edema Three-Year Outcomes of Individualized Ranibizumab Treatment in Patients with Diabetic Macular Edema
p:P50
wds:Q57767905-832BFA2A-B2E7-4DC6-A6F2-DA6A4DD24146 wds:Q57767905-4D1EF15C-85FA-4001-ABBC-F80BD3A1F4CE
wdt:P50
wd:Q71014505 wd:Q56524114
p:P1476
wds:Q57767905-370F2BD9-78F0-4F17-8EF9-0E397E0BE6A3
wdt:P1476
Three-Year Outcomes of Individualized Ranibizumab Treatment in Patients with Diabetic Macular Edema
p:P304
wds:Q57767905-0CB4A647-1020-4F5B-9DBD-270957F39597
wdt:P304
1045-1053
p:P31
wds:Q57767905-5BDBDB88-293F-4DFD-939F-C9CC0D3041F9
wdt:P31
wd:Q13442814
p:P921
wds:Q57767905-55596759-D771-4C61-9697-AC97AE68E52F wds:Q57767905-1D3FF98A-EC4B-45D3-B476-46630BDBC808
wdt:P921
wd:Q181600 wd:Q18558081
p:P698
wds:Q57767905-1373CFD4-EA6C-418A-BA8B-1914FE0FBFD6
wdtn:P698
n9:24491642
wdt:P698
24491642
p:P1433
wds:Q57767905-BFDF9652-AA09-43B8-96A8-180E9E9F4C69
wdt:P1433
wd:Q7098109
p:P433
wds:Q57767905-4AF50FB0-7916-4D7F-BD50-4CD865DF8DBF
p:P478
wds:Q57767905-1C2216EC-77FD-4F24-9428-3839F94C3FAC
wdt:P433
5
wdt:P478
121
p:P356
wds:Q57767905-A7D12910-4A00-4143-9D1D-4A99C4DB5CF7
wdtn:P356
n12:J.OPHTHA.2013.11.041
wdt:P356
10.1016/J.OPHTHA.2013.11.041